140 related articles for article (PubMed ID: 37184977)
1. Association of survival with adjuvant radiotherapy for pN0 esophageal cancer.
Gao H; Wang Y; Jiang Z; Shi G; Hu S; Ai J; Wang Z; Wei Y
Aging (Albany NY); 2023 Apr; 15(8):3158-3170. PubMed ID: 37184977
[TBL] [Abstract][Full Text] [Related]
2. Adjuvant radiotherapy for patients with pathologic node-negative esophageal carcinoma: A population based propensity matching analysis.
Gao HJ; Shang XB; Gong L; Zhang HD; Ren P; Shi GD; Wei YC; Yu ZT
Thorac Cancer; 2020 Feb; 11(2):243-252. PubMed ID: 31828980
[TBL] [Abstract][Full Text] [Related]
3. Role of radiation therapy in node-negative esophageal cancer: A propensity-matched analysis.
Gao HJ; Wei YC; Gong L; Ge N; Han B; Shi GD; Yu ZT
Thorac Cancer; 2020 Oct; 11(10):2820-2829. PubMed ID: 32790041
[TBL] [Abstract][Full Text] [Related]
4. The impact of adjuvant therapy on survival for node-negative esophageal squamous cell carcinoma: a propensity score-matched analysis.
Deng X; He W; Jiang Y; Deng S; Mao T; Leng X; Luo Q; Zheng K; Han Y
Ann Transl Med; 2021 Jun; 9(12):998. PubMed ID: 34277798
[TBL] [Abstract][Full Text] [Related]
5. Survival effect of neoadjuvant radiotherapy before esophagectomy for patients with esophageal cancer: a surveillance, epidemiology, and end-results study.
Schwer AL; Ballonoff A; McCammon R; Rusthoven K; D'Agostino RB; Schefter TE
Int J Radiat Oncol Biol Phys; 2009 Feb; 73(2):449-55. PubMed ID: 18538500
[TBL] [Abstract][Full Text] [Related]
6. Validity of upfront surgery for patients with unsuspected lymph node metastasis in esophageal cancer: a propensity scoring matching study.
Park JK; Kim JJ; Moon SW; Cho DG
J Cardiothorac Surg; 2018 Jun; 13(1):62. PubMed ID: 29880029
[TBL] [Abstract][Full Text] [Related]
7. The Impact of Adjuvant Postoperative Radiation Therapy and Chemotherapy on Survival After Esophagectomy for Esophageal Carcinoma.
Wong AT; Shao M; Rineer J; Lee A; Schwartz D; Schreiber D
Ann Surg; 2017 Jun; 265(6):1146-1151. PubMed ID: 27280504
[TBL] [Abstract][Full Text] [Related]
8. Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for clinical node-negative esophageal carcinoma.
Gao HJ; Wei YC; Gong L; Ge N; Han B; Shi GD; Yu ZT
Thorac Cancer; 2020 Sep; 11(9):2618-2629. PubMed ID: 32755068
[TBL] [Abstract][Full Text] [Related]
9. Difference in failure patterns of pT3-4N0-3M0 esophageal cancer treated by surgery
Zeng Y; Yu W; Liu Q; Yu WW; Zhu ZF; Zhao WX; Liu J; Wang JM; Fu XL; Liu Y; Cai XW
World J Gastrointest Oncol; 2019 Dec; 11(12):1172-1181. PubMed ID: 31908722
[TBL] [Abstract][Full Text] [Related]
10. Adjuvant radiotherapy for stage pN1M0 esophageal squamous cell carcinoma: Results from a Chinese two-center study.
Ni W; Chen J; Xiao Z; Yu S; Zhang W; Zhou Z; Chen D; Feng Q; Chen X; Lin Y; Zhu K; Gao S; Xue Q; Mao Y; Cheng G; Sun K; Liu X; Fang D
Thorac Cancer; 2019 Jun; 10(6):1431-1440. PubMed ID: 31102336
[TBL] [Abstract][Full Text] [Related]
11. Comparison of neoadjuvant chemotherapy versus upfront surgery with or without chemotherapy for patients with clinical stage III esophageal squamous cell carcinoma.
Matsuda S; Tsubosa Y; Sato H; Takebayashi K; Kawamorita K; Mori K; Niihara M; Tsushima T; Yokota T; Onozawa Y; Yasui H; Takeuchi H; Kitagawa Y
Dis Esophagus; 2017 Feb; 30(2):1-8. PubMed ID: 26919154
[TBL] [Abstract][Full Text] [Related]
12. Value of radiotherapy in addition to esophagectomy for stage II and III thoracic esophageal squamous cell carcinoma: Analysis of surveillance, epidemiology, and end results database.
Yu J; Ouyang W; Li Y; Hu J; Xu Y; Wei Y; Liao Z; Liu Y; Zhang J; Xie C
Cancer Med; 2019 Jan; 8(1):21-27. PubMed ID: 30561117
[TBL] [Abstract][Full Text] [Related]
13. Treatment of clinical T2N0M0 esophageal cancer.
Hardacker TJ; Ceppa D; Okereke I; Rieger KM; Jalal SI; LeBlanc JK; DeWitt JM; Kesler KA; Birdas TJ
Ann Surg Oncol; 2014 Nov; 21(12):3739-43. PubMed ID: 25047477
[TBL] [Abstract][Full Text] [Related]
14. Management of pathologic node-positive disease following initial surgery for clinical T1-2 N0 esophageal cancer: patterns of care and outcomes from the national cancer data base.
Haque W; Verma V; Bernicker E; Butler EB; Teh BS
Acta Oncol; 2018 Jun; 57(6):782-789. PubMed ID: 29188742
[TBL] [Abstract][Full Text] [Related]
15. Survival benefit of neoadjuvant versus adjuvant radiotherapy in lymph node positive esophageal cancer: a population based analysis.
Thumallapally N; Meshref A; Mousa M; Hendawi M; Lan M; Salem AI; Forte F
J Gastrointest Oncol; 2017 Oct; 8(5):825-832. PubMed ID: 29184686
[TBL] [Abstract][Full Text] [Related]
16. [Factors affecting on long-time survival in patients with stage Ⅲ thoracic esophageal carcinoma after esophagectomy].
Yang Q; Wang YX; He M; Li J; Qi Z; Zhu SC; Qiao XY
Zhonghua Zhong Liu Za Zhi; 2016 Jul; 38(7):530-7. PubMed ID: 27531268
[TBL] [Abstract][Full Text] [Related]
17. A propensity-score matching analysis comparing long-term survival of surgery alone and postoperative treatment for patients in node positive or stage III esophageal squamous cell carcinoma after R0 esophagectomy.
Yu S; Zhang W; Ni W; Xiao Z; Wang Q; Zhou Z; Feng Q; Zhang H; Chen D; Liang J; Lv J; Hui Z; He J; Gao S; Sun K; Fang D; Liu X; Li Y
Radiother Oncol; 2019 Nov; 140():159-166. PubMed ID: 31302346
[TBL] [Abstract][Full Text] [Related]
18. Endoscopic resection versus esophagectomy for patients with small-sized T1N0 esophageal cancer: A propensity-matched study.
Wang W; Chen D; Sang Y; Chen C; Zhang Y; Mao Y; Chen Y
Clin Res Hepatol Gastroenterol; 2021 May; 45(3):101543. PubMed ID: 33554864
[TBL] [Abstract][Full Text] [Related]
19. The impact of adjuvant radiotherapy on radically resected T3 esophageal squamous cell carcinoma.
Chen SB; Weng HR; Wang G; Liu DT; Li H; Zhang H; Chen YP
J Cancer Res Clin Oncol; 2016 Jan; 142(1):277-86. PubMed ID: 26328915
[TBL] [Abstract][Full Text] [Related]
20. Postoperative adjuvant chemotherapy versus chemoradiotherapy for node-positive esophageal squamous cell carcinoma: a propensity score-matched analysis.
Wang Q; Lang J; Li T; Peng L; Dai W; Jiang Y; Xie T; Fang Q; Wang Y; Wu L; Cao B; Han Y
Radiat Oncol; 2020 May; 15(1):119. PubMed ID: 32448253
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]